Intrinsiqs

Is RenovoRx, Inc. overvalued?

RenovoRx, Inc. (RNXT) — key valuation metrics and fundamentals.

No verdict
Price
$2.52
Fair value
Current P/E
Normal P/E
Market cap
$113.5M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares RNXT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 3 Sep 2026.